US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist

3.3800
+0.2900+9.39%

Close Jul 26 16:00 ET

3.3800
0.00000.00%

Post 20:01 ET

53.44MMarket Cap-7681P/E (TTM)

Lexaria Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)May 31, 2024

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

(FY)Aug 31, 2022

(Q4)Aug 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.11%-1.27M

49.55%-619.61K

5.11%-1.18M

-20.53%-5.88M

-37.83%-1.62M

-41.84%-1.79M

3.84%-1.23M

-6.77%-1.25M

-22.30%-4.88M

-5.79%-1.18M

Net income from continuing operations

25.14%-1.78M

50.20%-652.73K

33.02%-1.19M

9.09%-6.71M

17.46%-1.25M

1.44%-2.38M

9.53%-1.31M

11.69%-1.77M

-76.38%-7.38M

-14.23%-1.51M

Operating gains losses

----

98.92%-7.93K

----

Depreciation and amortization

56.75%39.2K

-35.58%15.93K

16.37%28.78K

41.55%145.4K

186.79%70.93K

4.68%25.01K

-5.48%24.73K

-11.46%24.73K

-30.41%102.72K

-61.24%24.73K

Other non cash items

-214.13%-14.79K

-9.12%18.3K

878.43%1.99K

-96.48%43.79K

-98.21%10.95K

-95.83%12.96K

-93.52%20.14K

-102.33%-255

1,238.68%1.24M

917.09%610.95K

Change In working capital

-84.10%76.32K

-137.46%-9.35K

-138.10%-134.55K

140.76%143.26K

-53.81%-714.85K

181.14%480.04K

123.36%24.96K

614.39%353.11K

-653.28%-351.48K

-10,594.41%-464.78K

-Change in receivables

451.00%124.56K

24.87%186.71K

-382.68%-408.05K

119.30%26.54K

93.69%-2.96K

-148.19%-35.49K

431.47%149.53K

29.03%-84.54K

-172.52%-137.49K

-124.60%-46.92K

-Change in inventory

--0

2,276.30%43.07K

--0

216.44%9.36K

171.71%2.92K

956.66%30.79K

-102.08%-1.98K

-68.70%7.22K

-Change in prepaid assets

63.65%-112.75K

-126.98%-134.49K

30.99%414.47K

111.64%29.98K

119.78%82.96K

-579.71%-310.15K

-488.21%-59.25K

285.74%316.42K

-87.75%-257.51K

-181.86%-419.45K

-Change in payables and accrued expense

-91.19%73.47K

16.24%-43.65K

-255.87%-140.97K

94.48%88.49K

-13,829.01%-783.65K

1,959.61%833.81K

28.56%-52.12K

8.19%90.44K

214.68%45.5K

91.88%-5.63K

-Change in other current liabilities

32.20%-8.96K

----

---44.81K

---11.2K

---13.21K

----

--0

Cash from discontinued investing activities

Operating cash flow

29.11%-1.27M

49.55%-619.61K

5.11%-1.18M

-20.53%-5.88M

-37.83%-1.62M

-41.84%-1.79M

3.84%-1.23M

-6.77%-1.25M

-22.30%-4.88M

-5.79%-1.18M

Investing cash flow

Cash flow from continuing investing activities

34.61%-22K

-74.37%-56.99K

-14.88%-40.03K

6.11%-169.61K

-36.75%-68.44K

11.35%-33.65K

5.05%-32.68K

40.15%-34.84K

-193.17%-180.64K

-2,502,150.00%-50.05K

Net PPE purchase and sale

--0

31.40%-33.75K

--0

---13.25K

51.62%-20.5K

---49.19K

---4

Net intangibles purchase and sale

34.61%-22K

-193.22%-56.99K

-179.08%-40.03K

-3.36%-135.86K

-36.76%-68.44K

-8.04%-33.65K

43.54%-19.44K

9.46%-14.34K

-65.36%-131.45K

---50.04K

Cash from discontinued investing activities

Investing cash flow

34.61%-22K

-74.37%-56.99K

-14.88%-40.03K

6.11%-169.61K

-36.75%-68.44K

11.35%-33.65K

5.05%-32.68K

40.15%-34.84K

-193.17%-180.64K

-2,502,150.00%-50.05K

Financing cash flow

Cash flow from continuing financing activities

194.67%5.04M

3.45M

1.82M

3,664.42%1.59M

-986.01%-121.69K

15,375.06%1.71M

-100.33%-44.6K

-100.28%-11.21K

Net issuance payments of debt

----

--0

----

33.13%-44.6K

-6.02%-11.21K

Net common stock issuance

--0

--2.96M

--1.25M

--1.59M

---121.69K

--1.71M

--0

Proceeds from stock option exercised by employees

--5.04M

--491.82K

--571.65K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

194.67%5.04M

--3.45M

--1.82M

3,664.42%1.59M

-986.01%-121.69K

15,375.06%1.71M

--0

-100.33%-44.6K

-100.28%-11.21K

Net cash flow

Beginning cash position

43.80%4.71M

-56.89%1.95M

-76.74%1.35M

-46.75%5.81M

-55.13%3.16M

-60.86%3.27M

-53.18%4.53M

-46.75%5.81M

743.89%10.92M

-13.04%7.05M

Current changes in cash

3,570.48%3.75M

320.17%2.78M

146.69%597.69K

12.61%-4.46M

-46.37%-1.81M

91.73%-108.2K

4.68%-1.26M

-3.61%-1.28M

-153.04%-5.1M

-144.06%-1.24M

Effect of exchange rate changes

---1.24K

---25K

--4.37K

----

--0

----

End cash Position

167.36%8.46M

43.80%4.71M

-56.89%1.95M

-76.74%1.35M

-55.13%3.16M

-60.86%3.27M

-53.18%4.53M

-46.75%5.81M

Free cash flow

29.21%-1.29M

46.34%-676.6K

4.57%-1.22M

-19.58%-6.05M

-37.78%-1.69M

-40.28%-1.82M

3.87%-1.26M

-4.54%-1.28M

-24.35%-5.06M

-10.29%-1.23M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)May 31, 2024	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022	(FY)Aug 31, 2022	(Q4)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.11%-1.27M	49.55%-619.61K	5.11%-1.18M	-20.53%-5.88M	-37.83%-1.62M	-41.84%-1.79M	3.84%-1.23M	-6.77%-1.25M	-22.30%-4.88M	-5.79%-1.18M
Net income from continuing operations	25.14%-1.78M	50.20%-652.73K	33.02%-1.19M	9.09%-6.71M	17.46%-1.25M	1.44%-2.38M	9.53%-1.31M	11.69%-1.77M	-76.38%-7.38M	-14.23%-1.51M
Operating gains losses	----	----	----	----	----	----	----	----	98.92%-7.93K	----
Depreciation and amortization	56.75%39.2K	-35.58%15.93K	16.37%28.78K	41.55%145.4K	186.79%70.93K	4.68%25.01K	-5.48%24.73K	-11.46%24.73K	-30.41%102.72K	-61.24%24.73K
Other non cash items	-214.13%-14.79K	-9.12%18.3K	878.43%1.99K	-96.48%43.79K	-98.21%10.95K	-95.83%12.96K	-93.52%20.14K	-102.33%-255	1,238.68%1.24M	917.09%610.95K
Change In working capital	-84.10%76.32K	-137.46%-9.35K	-138.10%-134.55K	140.76%143.26K	-53.81%-714.85K	181.14%480.04K	123.36%24.96K	614.39%353.11K	-653.28%-351.48K	-10,594.41%-464.78K
-Change in receivables	451.00%124.56K	24.87%186.71K	-382.68%-408.05K	119.30%26.54K	93.69%-2.96K	-148.19%-35.49K	431.47%149.53K	29.03%-84.54K	-172.52%-137.49K	-124.60%-46.92K
-Change in inventory	--0	--0	--0	2,276.30%43.07K	--0	216.44%9.36K	171.71%2.92K	956.66%30.79K	-102.08%-1.98K	-68.70%7.22K
-Change in prepaid assets	63.65%-112.75K	-126.98%-134.49K	30.99%414.47K	111.64%29.98K	119.78%82.96K	-579.71%-310.15K	-488.21%-59.25K	285.74%316.42K	-87.75%-257.51K	-181.86%-419.45K
-Change in payables and accrued expense	-91.19%73.47K	16.24%-43.65K	-255.87%-140.97K	94.48%88.49K	-13,829.01%-783.65K	1,959.61%833.81K	28.56%-52.12K	8.19%90.44K	214.68%45.5K	91.88%-5.63K
-Change in other current liabilities	32.20%-8.96K	----	----	---44.81K	---11.2K	---13.21K	----	----	--0	--0
Cash from discontinued investing activities
Operating cash flow	29.11%-1.27M	49.55%-619.61K	5.11%-1.18M	-20.53%-5.88M	-37.83%-1.62M	-41.84%-1.79M	3.84%-1.23M	-6.77%-1.25M	-22.30%-4.88M	-5.79%-1.18M
Investing cash flow
Cash flow from continuing investing activities	34.61%-22K	-74.37%-56.99K	-14.88%-40.03K	6.11%-169.61K	-36.75%-68.44K	11.35%-33.65K	5.05%-32.68K	40.15%-34.84K	-193.17%-180.64K	-2,502,150.00%-50.05K
Net PPE purchase and sale	--0	--0	--0	31.40%-33.75K	--0	--0	---13.25K	51.62%-20.5K	---49.19K	---4
Net intangibles purchase and sale	34.61%-22K	-193.22%-56.99K	-179.08%-40.03K	-3.36%-135.86K	-36.76%-68.44K	-8.04%-33.65K	43.54%-19.44K	9.46%-14.34K	-65.36%-131.45K	---50.04K
Cash from discontinued investing activities
Investing cash flow	34.61%-22K	-74.37%-56.99K	-14.88%-40.03K	6.11%-169.61K	-36.75%-68.44K	11.35%-33.65K	5.05%-32.68K	40.15%-34.84K	-193.17%-180.64K	-2,502,150.00%-50.05K
Financing cash flow
Cash flow from continuing financing activities	194.67%5.04M	3.45M	1.82M	3,664.42%1.59M	-986.01%-121.69K	15,375.06%1.71M	0	0	-100.33%-44.6K	-100.28%-11.21K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	33.13%-44.6K	-6.02%-11.21K
Net common stock issuance	--0	--2.96M	--1.25M	--1.59M	---121.69K	--1.71M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	--5.04M	--491.82K	--571.65K	----	----	--0	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	194.67%5.04M	--3.45M	--1.82M	3,664.42%1.59M	-986.01%-121.69K	15,375.06%1.71M	--0	--0	-100.33%-44.6K	-100.28%-11.21K
Net cash flow
Beginning cash position	43.80%4.71M	-56.89%1.95M	-76.74%1.35M	-46.75%5.81M	-55.13%3.16M	-60.86%3.27M	-53.18%4.53M	-46.75%5.81M	743.89%10.92M	-13.04%7.05M
Current changes in cash	3,570.48%3.75M	320.17%2.78M	146.69%597.69K	12.61%-4.46M	-46.37%-1.81M	91.73%-108.2K	4.68%-1.26M	-3.61%-1.28M	-153.04%-5.1M	-144.06%-1.24M
Effect of exchange rate changes	---1.24K	---25K	--4.37K	----	----	----	----	--0	----	----
End cash Position	167.36%8.46M	43.80%4.71M	-56.89%1.95M	-76.74%1.35M	-76.74%1.35M	-55.13%3.16M	-60.86%3.27M	-53.18%4.53M	-46.75%5.81M	-46.75%5.81M
Free cash flow	29.21%-1.29M	46.34%-676.6K	4.57%-1.22M	-19.58%-6.05M	-37.78%-1.69M	-40.28%-1.82M	3.87%-1.26M	-4.54%-1.28M	-24.35%-5.06M	-10.29%-1.23M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall